We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




EraGen and Bayer in License Agreement

By HospiMedica staff writers
Posted on 21 Jun 2005
EraGen Biosciences (Madison, WI, USA) has licensed its patented MultiCode-PLx system to Bayer HealthCare, Diagnostics Division (Tarrytown, NY, USA), in an exclusive worldwide agreement for cystic fibrosis (CF).

EraGen's MultiCode-PLx platform is a cost-effective, high-throughput genotyping system that simultaneously tests for predetermined mutations of the gene associated with cystic fibrosis, the cystic fibrosis transmembrane conductance regulator (CFTR) gene. More...
By leveraging isobases, the test substantially reduces the time for CF multi-mutation analysis compared to other testing systems. The test will allow the customers of Bayer Healthcare to enhance their level of CF clinical testing by reducing errors, providing faster turnaround, and lessening labor needs.

"Automated genetic diagnostics assays, including those for cystic fibrosis, are vital for the laboratory to take advantage of clinical progress, while maintaining lab efficiencies and providing timely, reliable clinical information,” stated Tony Bihl, president of Bayer HealthCare's Diagnostics Division.

The agreement between EraGen and Bayer also provides Bayer with additional rights, enabling the company to expand its presence in the genetics-based diagnostic testing market with a number of assays for other diseases.





Related Links:
EraGen
Bayer Diag.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Medical Examination & Procedure Light
Vega 80
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Even though the team’s new bioelectronic is only about the size of a fingertip, it could offer an effective and biocompatible approach to addressing high blood pressure (photo courtesy of Tao Zhou/Penn State)

Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study

Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.